ADouble-Blind, Placebo-Controlled Study of Valproate for Aggression in Youth with Pervasive Developmental Disorders
dc.contributor.author | Hellings, Jessica A. | en_US |
dc.contributor.author | Weckbaugh, Marilyn | en_US |
dc.contributor.author | Nickel, Elizabeth J. | en_US |
dc.contributor.author | Cain, Sharon E. | en_US |
dc.contributor.author | Zarcone, Jennifer R. | en_US |
dc.contributor.author | Reese, R. Matthew | en_US |
dc.contributor.author | Hall, Sandra | en_US |
dc.contributor.author | Ermer, David J. | en_US |
dc.contributor.author | Tsai, Luke Y. | en_US |
dc.contributor.author | Schroeder, Stephen R. | en_US |
dc.contributor.author | Cook, Edwin H. | en_US |
dc.date.accessioned | 2009-07-10T19:08:26Z | |
dc.date.available | 2009-07-10T19:08:26Z | |
dc.date.issued | 2005-09-01 | en_US |
dc.identifier.citation | Hellings, Jessica A.; Weckbaugh, Marilyn; Nickel, Elizabeth J.; Cain, Sharon E.; Zarcone, Jennifer R.; Reese, R. Matthew; Hall, Sandra; Ermer, David J.; Tsai, Luke Y.; Schroeder, Stephen R.; Cook, Edwin H. (2005). "ADouble-Blind, Placebo-Controlled Study of Valproate for Aggression in Youth with Pervasive Developmental Disorders." Journal of Child and Adolescent Psychopharmacology 15(4): 682-692 <http://hdl.handle.net/2027.42/63307> | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/63307 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=16190799&dopt=citation | en_US |
dc.description.abstract | Objective: The aim of this study was to study valproate efficacy and safety for aggression in children and adolescents with pervasive developmental disorders (PDD). Methods: In this prospective double-blind, placebo-controlled study, 30 subjects (20 boys, 10 girls) 6–20 years of age with PDD and significant aggression were randomized and received treatment with valproate (VPA) or placebo (PBO) for 8 weeks as outpatients. Mean VPA trough blood levels were 75.5 mcg/mL at week 4 and 77.8 mcg/mL at week 8. Results: No treatment difference was observed statistically between VPA and PBO groups. The Aberrant Behavior Checklist—Community Scale (ABC-C) Irritability subscale was the primary outcome measure (p = 0.65), and CGI—Improvement (p = 0.16) and OAS (p = 0.96) were secondary outcome measures. Increased appetite and skin rash were significant side effects. Only 1 subject was dropped from the study owing to side effects, notably a spreading skin rash, which then resolved spontaneously. Two subjects receiving VPA developed increased serum ammonia levels, one with an associated parent report of slurred speech and mild cognitive slowing. Poststudy, of 16 VPA and PBO subjects receiving VPA, 10 subjects demonstrated sustained response, 4 of whom later attempted taper, with significant relapse of aggression. Conclusion: The present negative findings cannot be viewed as conclusive, partly owing to the large placebo response, subject heterogeneity, and size of the groups. Larger studies are needed to expand upon these findings. | en_US |
dc.format.extent | 151384 bytes | |
dc.format.extent | 2489 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.publisher | Mary Ann Liebert, Inc., publishers | en_US |
dc.title | ADouble-Blind, Placebo-Controlled Study of Valproate for Aggression in Youth with Pervasive Developmental Disorders | en_US |
dc.type | Article | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.identifier.pmid | 16190799 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/63307/1/cap.2005.15.682.pdf | |
dc.identifier.doi | doi:10.1089/cap.2005.15.682 | en_US |
dc.identifier.source | Journal of Child and Adolescent Psychopharmacology | en_US |
dc.identifier.source | Journal of Child and Adolescent Psychopharmacology | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.